Psoriasis, a new challenge for laboratory medicine

被引:7
作者
Gulletta, Elio [1 ]
Bottoni, Ugo [2 ]
Foti, Daniela P. [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Clin Pathol Unit, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Dermatol Unit, I-88100 Catanzaro, Italy
关键词
analytical biomarkers; IL-17; IL-23; microarray assay; psoriasis; T-reg; SERUM-LEVELS; T-CELLS; GENETICS; MILD; SKIN; IMMUNOPATHOGENESIS; INTERLEUKIN-23; MECHANISMS; BIOMARKERS; PATHWAY;
D O I
10.1515/cclm-2012-0653
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Psoriasis is an immune-mediated, chronic, inflammatory disease that affects the skin and joints. Because of its high incidence and of its clinical symptoms it has a very strong social impact. In a genetically predisposed individual, the maintenance of the skin barrier integrity is strongly compromised in response to either environmental or self-antigenic insults. A persistent dys-regulation of the skin immune system causes the typical evolutive skin lesions of psoriasis and recurrence of the disease. The most efficient laboratory approach consists of a well-defined evaluation of immune response in order to help diagnosis, to monitor evolution, and to evaluate the effects of individualized therapeutic treatments.
引用
收藏
页码:1363 / 1368
页数:6
相关论文
共 59 条
[1]
DRUGS IN EXACERBATION OF PSORIASIS [J].
ABEL, EA ;
DICICCO, LM ;
ORENBERG, EK ;
FRAKI, JE ;
FARBER, EM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (05) :1007-1022
[2]
Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris [J].
Anderson, K. S. ;
Petersson, S. ;
Wong, J. ;
Shubbar, E. ;
Lokko, N. N. ;
Carlstrom, M. ;
Enerback, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (05) :1085-1089
[3]
Detection of psoriasin/S100A7 in the sera of patients with psoriasis [J].
Anderson, K. S. ;
Wong, J. ;
Polyak, K. ;
Aronzon, D. ;
EnerbAck, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (02) :325-332
[4]
[Anonymous], J RHEUMATOL
[5]
Psoriasis Comorbidities: Results from the National Psoriasis Foundation Surveys 2003 to 2011 [J].
Armstrong, April W. ;
Schupp, Clayton ;
Bebo, Bruce .
DERMATOLOGY, 2012, 225 (02) :121-126
[6]
Armstrong AW, 2012, ARCH DERMATOL, V15, P1
[7]
Combination Treatments for Psoriasis A Systematic Review and Meta-analysis [J].
Bailey, Elizabeth E. ;
Ference, Elisabeth H. ;
Alikhan, Ali ;
Hession, Meghan T. ;
Armstrong, April W. .
ARCHIVES OF DERMATOLOGY, 2012, 148 (04) :511-522
[8]
Natural Killer T Cells: An Unconventional T-Cell Subset with Diverse Effector and Regulatory Functions [J].
Balato, Anna ;
Unutmaz, Derya ;
Gaspari, Anthony A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (07) :1628-1642
[9]
Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis [J].
Benoit, S. ;
Toksoy, A. ;
Ahlmann, M. ;
Schmidt, M. ;
Sunderkoetter, C. ;
Foell, D. ;
Pasparakis, M. ;
Roth, J. ;
Goebeler, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) :62-66
[10]
Boulinguez S, 2011, Ann Dermatol Venereol, V138, pH1, DOI 10.1016/S0151-9638(11)70060-6